NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Ask the CEO Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured at this month’s Virtual Investor Ask the CEO Conference. CNS Pharmaceuticals CEO John Climaco is scheduled to participate in a live moderated webcast during the conference; the webcast is slated to start at 4 p.m. ET. The distinctive conference provides a unique opportunity for members of the investment community to ask questions directly to leaders of specific companies during the live event. According to the announcement, executive answer as many questions as possible during the interactive webcast. A replay of Climaco’s “Ask the CEO” presentation will be available on the company website following the event.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer